NASDAQ:CELC
Celcuity Inc Stock News
$16.76
-0.90 (-5.10%)
At Close: May 17, 2024
Coronavirus Scare Supports These Biotech ETFs & Stocks
12:00am, Tuesday, 24'th Mar 2020
Stocks Analysis by Zacks Investment Research covering: S&P 500, Dow Jones Industrial Average, Gilead Sciences Inc, Biogen Inc. Read Zacks Investment Research's latest article on Investing.com
Mar 18, 2020 (The Expresswire) --
Global “Hospital Acquired Infections (HAI) Diagnostics Market” Report 2020 is a comprehensive, professional report provides...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
Celcuity Reports Fourth Quarter and Full Year 2019 Financial Results
08:00pm, Thursday, 12'th Mar 2020
MINNEAPOLIS, MN / ACCESSWIRE / March 12, 2020 / Celcuity Inc. (NASDAQ:CELC), a functional cellular analysis company that is developing companion diagnostic tests designed to expand the eligible patien
Celcuity, Inc. to Host Earnings Call
06:30pm, Thursday, 12'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 12, 2020 / Celcuity, Inc. (NASDAQ:CELC) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 12, 2020 at 4:30 PM E
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
12:03pm, Wednesday, 11'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * A
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 9.)
Arcutis...
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
08:14pm, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.The week was light on news flow, barring some smid-cap earnings and COVID-19 treatment and vaccin
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
12:00am, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.
The week was light on news flow, barring some smid-cap earnings and...
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) * Arcus Biosciences Inc (NYSE: RCUS) * Arcturu
Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2019 Financial Results and Conference Call
09:15pm, Thursday, 27'th Feb 2020
MINNEAPOLIS, MN / ACCESSWIRE / February 27, 2020 / Celcuity Inc. (CELC), a functional cellular analysis company that is developing companion diagnostic tests designed to expand the eligible patient po
21 Diagnostics & Research Stocks Moving In Thursday's Session
05:53pm, Thursday, 23'rd Jan 2020
Gainers
• Co-Diagnostics, Inc. (NASDAQ:CODX) stock rose 107.1% to $2.34 during Thursday's regular session.
• Trinity Biotech, Inc. (NASDAQ:TRIB) stock surged...
The Zacks Analyst Blog Highlights: Red Robin, Celcuity, Atlas Air and Boston Private
04:07pm, Thursday, 12'th Dec 2019
The Zacks Analyst Blog Highlights: Red Robin, Celcuity, Atlas Air and Boston Private
MINNEAPOLIS, MN / ACCESSWIRE / December 11, 2019 / Celcuity Inc. (Nasdaq:CELC), a dynamic cellular analysis company developing diagnostic tests to identify new patient populations for targeted therapi
